https://www.selleckchem.com/pr....oducts/vx803-m4344.h
Survival difference was significant between Milan patients with AFP≤ 2500 ng/mL and those with AFP 2500 ng/mL (59.1% vs 37.4%; P .001). The mean 5-year survival was 55% for beyond Milan within UCSF patients with AFP≤ 150 ng/mL and 35.7% for those with AFP 150 ng/mL (P= .003). AFP level should be incorporated in the selection criteria for HCC patients considered for OLT. Milan patients with an AFP level exceeding 2500 ng/mL have reduced survival. Patients with tumors beyond Milan and within UCSF criteria whose AFP≤ 150
پسندیدن
اظهار نظر
اشتراک گذاری
